{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Apexigen, Inc."},"Symbol":{"label":"Symbol","value":"APGN"},"Address":{"label":"Address","value":"75 SHOREWAY ROAD SUITE C, SAN CARLOS, California, 94070, United States"},"Phone":{"label":"Phone","value":"+1 650 931-6236"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Apexigen Inc is a clinical-stage biopharmaceutical company focusing on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. The company's pipeline of immuno-oncology therapeutic candidates is led by sotigalimab, which is in clinical development, and also includes several preclinical stage immune-oncology programs."},"CompanyUrl":{"label":"Company Url","value":"https://www.brooklinecapitalacquisitioncorp.com"},"KeyExecutives":{"label":"Key Executives","value":[]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}